JP2009544314A5 - - Google Patents

Download PDF

Info

Publication number
JP2009544314A5
JP2009544314A5 JP2009521815A JP2009521815A JP2009544314A5 JP 2009544314 A5 JP2009544314 A5 JP 2009544314A5 JP 2009521815 A JP2009521815 A JP 2009521815A JP 2009521815 A JP2009521815 A JP 2009521815A JP 2009544314 A5 JP2009544314 A5 JP 2009544314A5
Authority
JP
Japan
Prior art keywords
seq
nucleotide position
nucleotide
change
deletion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009521815A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009544314A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/016705 external-priority patent/WO2008094194A2/en
Publication of JP2009544314A publication Critical patent/JP2009544314A/ja
Publication of JP2009544314A5 publication Critical patent/JP2009544314A5/ja
Pending legal-status Critical Current

Links

JP2009521815A 2006-07-24 2007-07-24 Pkdの変異およびその評価 Pending JP2009544314A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83278006P 2006-07-24 2006-07-24
PCT/US2007/016705 WO2008094194A2 (en) 2006-07-24 2007-07-24 Pkd mutations and evaluation of same

Publications (2)

Publication Number Publication Date
JP2009544314A JP2009544314A (ja) 2009-12-17
JP2009544314A5 true JP2009544314A5 (https=) 2010-10-07

Family

ID=39674638

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009521815A Pending JP2009544314A (ja) 2006-07-24 2007-07-24 Pkdの変異およびその評価

Country Status (4)

Country Link
US (4) US8771946B2 (https=)
JP (1) JP2009544314A (https=)
CA (3) CA3081362C (https=)
WO (1) WO2008094194A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008094194A2 (en) 2006-07-24 2008-08-07 Athena Diagnostics, Inc. Pkd mutations and evaluation of same
GB201410693D0 (en) 2014-06-16 2014-07-30 Univ Southampton Splicing modulation
AU2015327836B2 (en) 2014-10-03 2021-07-01 Cold Spring Harbor Laboratory Targeted augmentation of nuclear gene output
US10538812B2 (en) 2014-11-19 2020-01-21 Otsuka Pharmaceutical Co., Ltd. Primer set and method for amplifying exons of PKD1 gene and PKD2 gene
CN108603230A (zh) 2015-10-09 2018-09-28 南安普敦大学 基因表达的调节与蛋白质表达失调的筛选
US11096956B2 (en) 2015-12-14 2021-08-24 Stoke Therapeutics, Inc. Antisense oligomers and uses thereof
WO2017106377A1 (en) 2015-12-14 2017-06-22 Cold Spring Harbor Laboratory Antisense oligomers for treatment of autosomal dominant mental retardation-5 and dravet syndrome
JP2018538287A (ja) * 2015-12-14 2018-12-27 コールド スプリング ハーバー ラボラトリー 多発性嚢胞腎の処置のためのアンチセンスオリゴマー
KR102318434B1 (ko) 2017-08-25 2021-11-01 스톡 테라퓨틱스, 인크. 병태 및 질환 치료용 안티센스 올리고머
CA3099280A1 (en) 2018-05-04 2019-11-07 Stoke Therapeutics, Inc. Methods and compositions for treatment of cholesteryl ester storage disease
AU2020227825B2 (en) 2019-02-27 2026-03-26 Stoke Therapeutics, Inc. Antisense oligomers for treatment of conditions and diseases
CN115867657A (zh) 2020-05-11 2023-03-28 斯托克制药公司 用于治疗疾患和疾病的opa1反义寡聚物
CN115725716B (zh) * 2022-09-20 2024-04-30 湖南家辉生物技术有限公司 Pkd1致病突变基因及在制备多囊肾病诊断试剂盒中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1322795A (en) * 1993-12-24 1995-07-17 Erasmus University Rotterdam Tuberous sclerosis 2 gene and uses thereof
US6867288B1 (en) 1994-10-12 2005-03-15 Genzyme Corporation Polycystic kidney disease gene
US6031088A (en) * 1996-05-23 2000-02-29 Albert Einstein College Of Medicine Of Yeshiva University Polycystic kidney disease PKD2 gene and uses thereof
US6100386A (en) * 1996-11-01 2000-08-08 Cold Spring Harbor Laboratory Human gene/protein involved in chronic myelogenous leukemia
CA2395781C (en) * 2000-07-13 2010-04-13 The Johns Hopkins University School Of Medicine Detection and treatment of polycystic kidney disease
US7273701B2 (en) * 2001-10-12 2007-09-25 Athena Diagnostics, Inc. Compositions and methods for genetic analysis of polycystic kidney disease
US6916619B2 (en) * 2001-10-12 2005-07-12 Athena Diagnostics, Inc. Compositions and methods for genetic analysis of polycystic kidney disease
CA2872385C (en) 2003-04-11 2019-01-15 Athena Diagnostics, Inc. Compositions and methods for genetic analysis of polycystic kidney disease
WO2008094194A2 (en) 2006-07-24 2008-08-07 Athena Diagnostics, Inc. Pkd mutations and evaluation of same

Similar Documents

Publication Publication Date Title
JP2009544314A5 (https=)
Ehrenkaufer et al. Identification of developmentally regulated genes in Entamoeba histolytica: insights into mechanisms of stage conversion in a protozoan parasite
JP2020505920A5 (https=)
US20120220478A1 (en) Methods for assessing disease risk
JP2008526249A5 (https=)
JP2008546403A5 (https=)
JP2010075182A5 (https=)
WO2007130519A3 (en) Viral nucleic acid microarray and method of use
JP2014533949A5 (https=)
JP2014509189A5 (https=)
JP2011519275A5 (https=)
KR101546058B1 (ko) 대사증후군 예측용 snp 마커 및 이의 용도
JP2011528903A5 (https=)
JP2011530312A5 (https=)
KR20090078341A (ko) Dnaj 유전자를 사용한 박테리아의 검출, 및 그의 용도
CN107858423B (zh) 用于预测心源性猝死易感性的试剂盒
JP2013544536A5 (https=)
WO2008016615A3 (en) Methods for high sensitivity detection of genetic polymorphisms
Chen et al. Transcriptomes of six mutants in the Sen1 pathway reveal combinatorial control of transcription termination across the Saccharomyces cerevisiae genome
EP2689034B1 (en) Role of ifng methylation in inflammatory bowel disease
CA2608161A1 (en) Methods for the assesssment of risk of developing lung cancer using analysis of genetic polymorphisms
CN102827834B (zh) 甲亢疾病的易感基因及其应用
JP5427352B2 (ja) ヒト体脂肪量と関連する遺伝子多型に基づく肥満発症リスクの判定方法
KR102438915B1 (ko) 표적 염기 배열을 검출하는 방법 프로브를 설계 및 제조하는 방법 및 키트
JP4491276B2 (ja) 標的dna配列において一塩基変異多型の存在を検出する方法及びキット